Author

John de Groot

Institution: The University of Texas MD Anderson Cancer Center

Observed institutions: The University of Texas MD Anderson Cancer Center, University of California, San Francisco

ORCID: 0000-0003-1454-6461

Observed ORCID: 0000-0003-1454-6461

OpenAlex ID: A5103976411

Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment

2021 · Karine A Al Feghali, James W Randall, et al. · Neuro-Oncology Advances · 5

Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial

2026 · Byram H Ozer, Adam L Cohen, et al. · Neuro-Oncology Advances

Ctni-66. Cern 09-02: a Phase 2 Trial of Carboplatin and Bevacizumab for Recurrent Adult Ependymoma

2025 · Shuodan Zhang, Byram Ozer, et al. · Neuro-Oncology

Works count: 3

Citation count: 5

H-index: 1

I10-index: